Evidence map›Paper›PMID 41303705›Full record

ArticleInternational journal of molecular sciences2025

Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy.

Betül Okur Altındaş, Sedat Öktem, Kürşat Bora Çarman, Mahmut Selman Yıldırım

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Betül Okur AltındaşDepartment of Medical Genetics, Necmettin Erbakan University Medical Faculty Hospital, Konya 42090, Türkiye.
Sedat ÖktemDivision of Pediatric Pulmonary Diseases, Department of Pediatrics, Medipol Mega University Hospital, İstanbul 34214, Türkiye.
Kürşat Bora ÇarmanDivision of Pediatric Neurology, Department of Pediatrics, Osmangazi University Medical Faculty Hospital, Eskişehir 26040, Türkiye.
Mahmut Selman YıldırımDepartment of Medical Genetics, Necmettin Erbakan University Medical Faculty Hospital, Konya 42090, Türkiye.

Funding

Necmettin Erbakan University 23TU18010
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by biallelic

Indexed as

Muscular Atrophy, SpinalTelomereTelomere HomeostasisAdolescentCase-Control StudiesChildChild, PreschoolFemaleGenetic TherapyHumansInfantMaleSurvival of Motor Neuron 1 ProteinSMN1 protein, humanSurvival of Motor Neuron 1 ProteinSMASMN1spinal muscular atrophytelomere length

Identifiers

PMID41303705
PMCPMC12653482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.